While I am glad that our cash position is much bet

While I am glad that our cash position is much better as a result of this offer and glad for the loyal CYDY shareholders who hold warrants, I am not happy to raise funds at a 40% discount (~$.27/$.46 to what I believe is already significantly undervalued share price). I do use 600M shares in all my calculations (and will raise to 700M if the vote passes), but that doesn't mean I want to raise funds at these levels. Essentially they have already offered shares they do not have (I know the offer addresses this). Although, I'm not that excited by this offer, it is better than trying to raise new funds.......but less positive than licensing the PCa test for example. My hope is this is a necessary evil at this point and the longer term intent/plan is to reward investors who have been loyal to the company thus far.

This also implies that a license deal may not be very close. I am okay with this and if they keep HIV and go alone it may work out very well, however until we get to the point of revenues it is also more risky.....or is this a move in preparation to raise the MC for those looking to buy us out? This would align with all the recent preclinical studies to try and add value. Maybe during one of the meetings with GILD or someone they balked and said for $XX to license GvHD and HIV, we could buy your entire company that has a MC of $150M for another nickel??

I do like the additions of the 2 hires announced today.

Seems I am in the minority though as most other feedback is positive.

Please do your own due diligence. All my posts and comments are not to be considered investment advice.